AbbVie at SOT 2027

Mar 14–17, 2027 San Antonio, TX ~4k attendees Website

AbbVie takes part in 3 sessions at SOT 2027 in San Antonio. Its people chair a session on eye side effects of drugs that reach the whole body and speak on a mouse model of eye toxicity from antibody-drug conjugates and on safety testing for CAR T cells made inside the body with lipid nanoparticles. It also joins a related course.

OrganizationSOT 2027 Attendance
AbbVie
North Chicago, IL
Pharma, chemical and consumer-product companies
Biopharmaceutical company developing medicines across several therapeutic areas.
Course
Sun, Mar 14
1:15pm–5:00pm
PM13: Ocular Toxicity of Systemically Administered Therapeutics
Ocular Toxicology · Biotechnology
Talk
Wed, Mar 17
3:25pm–3:45pm
Nonclinical Safety Assessment of LNP-Delivered In Vivo CAR T Cells
Stars at Night Ballroom B2, Convention Center
Biotechnology · Nanoscience and Advanced Materials

Explore the full SOT 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SOT 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at AbbVie

Tell us what you sell and we’ll find the people at AbbVie most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Society of Toxicology. Organization details are derived from SOT’s published ToxExpo exhibitor list, its online program planner and each exhibitor’s own profile and website. Submit a correction